Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Guanfacine for Smoking Cessation
NCT04198116Phase 2Completed
- Sponsor
- Yale University
- Start
- Nov 2020
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in Tobacco Use Disorder (TUD), sponsored by Yale University. Started Nov 2020; status: completed.
02
Drugs
guanfacine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04198116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04198116.